These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 7559507

  • 1. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.
    Tartare-Deckert S, Sawka-Verhelle D, Murdaca J, Van Obberghen E.
    J Biol Chem; 1995 Oct 06; 270(40):23456-60. PubMed ID: 7559507
    [Abstract] [Full Text] [Related]

  • 2. Evidence for the direct interaction of the insulin-like growth factor I receptor with IRS-1, Shc, and Grb10.
    Dey BR, Frick K, Lopaczynski W, Nissley SP, Furlanetto RW.
    Mol Endocrinol; 1996 Jun 06; 10(6):631-41. PubMed ID: 8776723
    [Abstract] [Full Text] [Related]

  • 3. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain.
    Gustafson TA, He W, Craparo A, Schaub CD, O'Neill TJ.
    Mol Cell Biol; 1995 May 06; 15(5):2500-8. PubMed ID: 7537849
    [Abstract] [Full Text] [Related]

  • 4. Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591-786.
    Sawka-Verhelle D, Tartare-Deckert S, White MF, Van Obberghen E.
    J Biol Chem; 1996 Mar 15; 271(11):5980-3. PubMed ID: 8626379
    [Abstract] [Full Text] [Related]

  • 5. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA, Surmacz E.
    Cancer Res; 1997 Jul 01; 57(13):2606-10. PubMed ID: 9205064
    [Abstract] [Full Text] [Related]

  • 6. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
    Kim B, Cheng HL, Margolis B, Feldman EL.
    J Biol Chem; 1998 Dec 18; 273(51):34543-50. PubMed ID: 9852124
    [Abstract] [Full Text] [Related]

  • 7. Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains.
    He W, O'Neill TJ, Gustafson TA.
    J Biol Chem; 1995 Oct 06; 270(40):23258-62. PubMed ID: 7559478
    [Abstract] [Full Text] [Related]

  • 8. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C, Valverde AM, Kahn CR, Benito M.
    Diabetes; 2002 Mar 06; 51(3):743-54. PubMed ID: 11872675
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a direct interaction between insulin receptor substrate-1 and Shc.
    Kasus-Jacobi A, Perdereau D, Tartare-Deckert S, Van Obberghen E, Girard J, Burnol AF.
    J Biol Chem; 1997 Jul 04; 272(27):17166-70. PubMed ID: 9202037
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.
    Soon L, Flechner L, Gutkind JS, Wang LH, Baserga R, Pierce JH, Li W.
    Mol Cell Biol; 1999 May 04; 19(5):3816-28. PubMed ID: 10207105
    [Abstract] [Full Text] [Related]

  • 11. Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor.
    Craparo A, O'Neill TJ, Gustafson TA.
    J Biol Chem; 1995 Jun 30; 270(26):15639-43. PubMed ID: 7541045
    [Abstract] [Full Text] [Related]

  • 12. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y, Tobe K, Kadowaki H, Katsumata D, Fukushima Y, Yazaki Y, Akanuma Y, Kadowaki T.
    Endocrinology; 1997 Feb 30; 138(2):741-50. PubMed ID: 9003010
    [Abstract] [Full Text] [Related]

  • 13. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins.
    Solow BT, Harada S, Goldstein BJ, Smith JA, White MF, Jarett L.
    Mol Endocrinol; 1999 Oct 30; 13(10):1784-98. PubMed ID: 10517679
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T, Ishiki M, Sawa T, Ishihara H, Takata Y, Imamura T, Usui I, Olefsky JM, Kobayashi M.
    Endocrinology; 1996 Oct 30; 137(10):4427-34. PubMed ID: 8828504
    [Abstract] [Full Text] [Related]

  • 15. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L, Zhou T, Jiang J, Pierce JH, Gustafson TA, Frank SJ.
    Endocrinology; 1999 May 30; 140(5):1972-83. PubMed ID: 10218944
    [Abstract] [Full Text] [Related]

  • 16. Interaction of SH2-containing protein tyrosine phosphatase 2 with the insulin receptor and the insulin-like growth factor-I receptor: studies of the domains involved using the yeast two-hybrid system.
    Rocchi S, Tartare-Deckert S, Sawka-Verhelle D, Gamha A, van Obberghen E.
    Endocrinology; 1996 Nov 30; 137(11):4944-52. PubMed ID: 8895367
    [Abstract] [Full Text] [Related]

  • 17. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
    Ward CW, Gough KH, Rashke M, Wan SS, Tribbick G, Wang J.
    J Biol Chem; 1996 Mar 08; 271(10):5603-9. PubMed ID: 8621421
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor-I receptor and insulin receptor association with a Src homology-2 domain-containing putative adapter.
    Wang J, Riedel H.
    J Biol Chem; 1998 Feb 06; 273(6):3136-9. PubMed ID: 9452421
    [Abstract] [Full Text] [Related]

  • 19. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM, Lorenzo M, Pons S, White MF, Benito M.
    Mol Endocrinol; 1998 May 06; 12(5):688-97. PubMed ID: 9605931
    [Abstract] [Full Text] [Related]

  • 20. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
    Isakoff SJ, Yu YP, Su YC, Blaikie P, Yajnik V, Rose E, Weidner KM, Sachs M, Margolis B, Skolnik EY.
    J Biol Chem; 1996 Feb 23; 271(8):3959-62. PubMed ID: 8626723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.